fda bpc-157 safety warning compounding Targets GLP-1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Regeneration or Risk? A Narrative
Description
In a clinical trial of tirzepatide injection for T2DM, hypoglycemia was increased when tirzepatide was used in combination with a sulfonylurea or insulin
Some patients might then continue with weekly injections at 100 mg as maintenance
Oral vs Injectable BPC-157: What Is Available in Thailand
Well, they are obviously the same medication but how you take it makes ALL of the difference
